NES
PJP icon

New England Securities’s Invesco Pharmaceuticals ETF PJP Stock Holding History

New England Securities’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$2.94M Buy
44,248
+804
+2% +$53.5K 1.03% 11
2014
Q3 		$2.77M Buy
43,444
+2,820
+7% +$174K 0.97% 13
2014
Q2 		$2.48M Sell
40,624
-158
-0.4% -$9.16K 0.86% 14
2014
Q1 		$2.31M Buy
40,782
+9,331
+30% +$530K 0.89% 15
2013
Q4 		$1.68M Buy
31,451
+13,029
+71% +$652K 0.7% 23
2013
Q3 		$848K Buy
18,422
+8,110
+79% +$370K 0.43% 53
2013
Q2 		$436K Buy
+10,312
New +$429K 0.29% 80

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
FIG
FundX Investment Group San Francisco, California $411M AUM 22.05% 1-Year Est. Return
PFG
Pacific Financial Group Bellevue, Washington $186M AUM 16.59% 1-Year Est. Return
SCM
Summit Capital Management Seattle, Washington $221M AUM 4.14% 1-Year Est. Return

New England Securities's PJP Position: Q4 2014 in Review

New England Securities increased its Invesco Pharmaceuticals ETF (PJP) stake by 1.9% in Q4 2014, buying an estimated $53.5K and bringing the position to 44,248 shares worth $2.94M. The position accounts for 1.03% of the portfolio, ranked #11.

New England Securities first reported a position in PJP in Q2 2013 and has held it in 7 quarters since. 97 funds tracked by Wall St. Rank hold PJP as of Q4 2014.

  • New England Securities held 44,248 shares of Invesco Pharmaceuticals ETF worth $2.94M as of Q4 2014.
  • New England Securities bought 804 Invesco Pharmaceuticals ETF shares in Q4 2014, an estimated $53.5K.
  • Invesco Pharmaceuticals ETF made up 1.03% of New England Securities's portfolio in Q4 2014, its #11 holding.
  • New England Securities first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and has held it in 7 quarters since.
  • 97 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.